NEUARTIGE FORMULIERUNGEN VON TUMOR-ASSOZIIERTEN PEPTIDEN, WELCHE AN MENSCHLICHE LEUKOZYTENANTIGENE DER KLASSE I ODER II FÜR IMPFUNGEN BINDEN

摘要

The present invention relates to novel formulations of tumour-associated peptides binding to human leukocyte antigen (HLA) class I or II molecules as vaccines for the use in immunotherapeutic methods. In particular, the present invention relates to formulations for the immunotherapy of cancer, in particular renal cancer. The present invention furthermore relates to vaccine compositions for eliciting anti-tumour immune responses.